NEW YORK, Nov. 21, 2017 — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, … Read More
The post Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid … appeared first on Dagga Magazine.